Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects

NCT00417794 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT00417794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2005
Completion date
April 22, 2015
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder (add), attention deficit disorder with hyperactivity (adhd), fetal alcohol syndrome